Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last --
Change Today 0.00 / 0.00%
Volume 0.0
1011 On Other Exchanges
Symbol
Exchange
1011 is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

china nt pharma group co ltd (1011) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
0.0
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for CHINA NT PHARMA GROUP CO LTD (1011)

Related News

No related news articles were found.

china nt pharma group co ltd (1011) Related Businessweek News

No Related Businessweek News Found

china nt pharma group co ltd (1011) Details

China NT Pharma Group Company Limited, together with its subsidiaries, operates as a third-party promotional and sales services provider of pharmaceuticals and vaccines in the People’s Republic of China. It operates in three segments: Third-Party Pharmaceutical Promotion and Sales; Proprietary Products Production and Sales; and Third-Party Vaccines and Other Pharmaceuticals. The Third-Party Pharmaceutical Promotion and Sales segment engages in selling and marketing third-party manufactured pharmaceutical products to customers, as well as providing marketing and promotion services. The Proprietary Products Production and Sales segment is involved in the production and sale of NT branded products and generic drugs. The Third-Party Vaccines and Other Pharmaceuticals segment provides supply chain services for pharmaceutical/vaccine products. The company also offers logistics and consulting services. China NT Pharma Group Company Limited was founded in 1995 and is headquartered in Shanghai, the People's Republic of China.

283 Employees
Last Reported Date: 08/6/15
Founded in 1995

china nt pharma group co ltd (1011) Top Compensated Officers

Chairman, Chief Executive Officer, Chairman o...
Total Annual Compensation: CNY4.8M
Executive Director
Total Annual Compensation: --
Honorary Advisor
Total Annual Compensation: CNY2.0M
Compensation as of Fiscal Year 2014.

china nt pharma group co ltd (1011) Key Developments

China NT Pharma Group Company Limited Reports Unaudited Consolidated Earnings Results for the Six Months Ended June 30, 2015

China NT Pharma Group Company Limited reported unaudited consolidated earnings results for the six months ended June 30, 2015. For the period, the company reported revenue of RMB 380,903,000 compared with RMB 408,099,000 for the same period last year. Profit from operations was RMB 57,181,000 compared with RMB 39,545,000 for the same period last year. Profit attributable to equity shareholders of the company was RMB 36,490,000 or 2.84 cents diluted per share compared with RMB 2,294,000 or 0.21 cents diluted per share for the same period last year. Profit before taxation was RMB 38,161,000 compared with RMB 3,145,000 for the same period last year. The decrease in revenue was primarily due to the decrease in revenue from the third-party pharmaceutical promotion and sales business. Total capital expenditure decreased by RMB 31.2 million or 69.3% to RMB 13.8 million for the six months ended 30 June 2015, as compared to RMB 45.0 million for the corresponding period in 2014.

China NT Pharma Group Company Limited to Report Q2, 2015 Results on Aug 06, 2015

China NT Pharma Group Company Limited announced that they will report Q2, 2015 results on Aug 06, 2015

China NT Pharma Group Company Limited, Board Meeting, Aug 06, 2015

China NT Pharma Group Company Limited, Board Meeting, Aug 06, 2015. Agenda: To consider approved the interim results of the company and its subsidiaries for the six months ended June 30, 2015 and its publication and considering the payment of an interim dividend, if any.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
1011:HK $1.69 HKD +0.05

1011 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 1011.
View Industry Companies
 

Industry Analysis

1011

Industry Average

Valuation 1011 Industry Range
Price/Earnings 37.1x
Price/Sales 1.7x
Price/Book 3.4x
Price/Cash Flow 48.1x
TEV/Sales 1.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CHINA NT PHARMA GROUP CO LTD, please visit www.ntpharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.